The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study

被引:49
作者
Anastos, K
Kalish, LA
Hessol, N
Weiser, B
Melnick, S
Burns, D
Delapenha, R
DeHovitz, J
Cohen, M
Meyer, W
Bremer, J
Kovacs, A
机构
[1] Montefiore Med Ctr, Bronx, NY 10467 USA
[2] New England Res Inst, Watertown, MA 02172 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA
[5] NCI, Bethesda, MD 20892 USA
[6] NICHHD, Bethesda, MD 20892 USA
[7] Howard Univ, Sch Med, Washington, DC 20059 USA
[8] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
[9] Cook Cty Hosp, Chicago, IL 60612 USA
[10] Quest Diagnost, Baltimore, MD USA
[11] Rush Med Coll, Chicago, IL 60612 USA
[12] Univ So Calif, Los Angeles, CA USA
关键词
HIV; survival; women; HIV-1; RNA; CD4 cell count;
D O I
10.1097/00002030-199909100-00016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To determine factors associated with survival and to assess the relative strength of CD4 cell count and HIV-1 RNA in predicting survival in a cohort of HIV 1-infected women. Design: Prospective cohort, enrolled during 1994-1995, with median follow-up of 29 months Results: Of 1769 HIV-infected women 252 died. In multivariate analyses, lower CD4 cell count, higher quantitative plasma HIV-1 RNA, and the presence of a self-reported AIDS-defining (Class C) condition were significantly associated with shorter survival: the relative hazard (RH) of dying was 1.17, 3.27, and 8.46, respectively for women with baseline CD4 cell count of 200-349, 50-199, and < 50 x 10(6) cells/l, compared with women with CD4 cell count of greater than or equal to 350 x 10(6) cells/l. Compared with women with HIV-1 RNA levels of < 4000 copies/ml plasma, the RH of dying for women with baseline quantitative HIV-1 RNA:measurements of 4000-20 000, 20 000-100 000, 100 000-500 000 and > 500 000 copies/ml, was 2.19, 2.17, 3.16, and 7.25, respectively. CD4 cell count had as strong a prognostic value as HIV-1 RNA level, particularly among participants with more advanced immunodeficiency. When the analysis was adjusted to eliminate the distortion created by having disproportionately sized strata of the categorized variables, the relative hazard of death associated with CD4 cell count became even larger in comparison with that for HIV-1 RNA. Eliminating from the analysis all follow up time during which participants could have received highly active antiretroviral therapy did not change these findings. Age was not a predictor of survival after adjustment for covariates. Conclusions: CD4 cell count and HIV-1 RNA had similar prognostic value in this cohort of HIV-1-infected women. Even in the presence of a low viral burden, a substantially decreased CD4 cell count remained a strong predictor of mortality. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:1717 / 1726
页数:10
相关论文
共 41 条
  • [1] ANASTOS K, 1999, 6 C RETR OPP INF CHI
  • [2] [Anonymous], 1996, Lancet, V348, P283
  • [3] The Women's Interagency HIV Study
    Barkan, SE
    Melnick, SL
    Preston-Martin, S
    Weber, K
    Kalish, LA
    Miotti, P
    Young, M
    Greenblatt, R
    Sacks, H
    Feldman, J
    [J]. EPIDEMIOLOGY, 1998, 9 (02) : 117 - 125
  • [4] BRABAZON C, 1998, 12 INT C AIDS GEN JU
  • [5] HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial
    BrunVezinet, F
    Boucher, C
    Loveday, C
    Descamps, D
    Fauveau, V
    Izopet, J
    Jeffries, D
    Kaye, S
    Krzyanowski, C
    Nunn, A
    Schuurman, R
    Seigneurin, JM
    Tamalet, C
    Tedder, R
    Weber, J
    Weverling, GJ
    Aber, V
    Aboulker, JP
    Babiker, AG
    Bragman, K
    Breckenridge, AM
    Carbon, C
    Charreau, I
    Chene, G
    Collis, P
    Cooper, D
    Darbyshire, JH
    Dormont, J
    Fiddian, P
    Flepp, M
    Gazzard, B
    Goebel, FD
    Hooker, M
    Lange, J
    Luthy, R
    Peto, TEA
    Reiss, P
    Seligmann, M
    Stone, AB
    Thomis, J
    Vella, S
    Walckenaer, G
    Warrell, D
    Weller, IVD
    Wilber, R
    Yeni, P
    Yeo, J
    Withnall, R
    Babiker, A
    Bloch, J
    [J]. LANCET, 1997, 350 (9083) : 983 - 990
  • [6] Postmenopausal hormone replacement: Effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors
    Burleson, MH
    Malarkey, WB
    Cacioppo, JT
    Poehlmann, KM
    Kiecolt-Glaser, JK
    Berntson, GG
    Glaser, R
    [J]. PSYCHOSOMATIC MEDICINE, 1998, 60 (01): : 17 - 25
  • [7] Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia
    Bush, CE
    Donovan, RM
    Markowitz, N
    Baxa, D
    Kvale, P
    Saravolatz, LD
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) : 970 - 972
  • [8] RACE, SEX, DRUG-USE, AND PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE
    CHAISSON, RE
    KERULY, JC
    MOORE, RD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (12) : 751 - 756
  • [9] Delmas MC, 1997, AIDS, V11, P1071
  • [10] AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: Markers with reciprocal predictive value over time after seroconversion
    deWolf, F
    Spijkerman, I
    Schellekens, PT
    Langendam, M
    Kuiken, C
    Bakker, M
    Roos, M
    Coutinho, R
    Miedema, F
    Goudsmit, J
    [J]. AIDS, 1997, 11 (15) : 1799 - 1806